Tolerance	tolerance	O	O	O	O
and	and	O	O	O	O
antiviral	antiviral	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Argentine	argentine	O	O	OTHERS	I
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
fever	fever	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Tolerance	tolerance	O	O	O	O
and	and	O	O	O	O
antiviral	antiviral	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
6	6	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Argentine	argentine	O	O	OTHERS	I
hemorrhagic	hemorrhagic	O	DISEASE	OTHERS	I
fever	fever	O	DISEASE	OTHERS	I
(	(	O	O	O	O
AHF	ahf	O	O	OTHERS	I
)	)	O	O	O	O
of	of	O	O	O	O
more	more	O	O	O	O
than	than	O	O	O	O
8	8	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
evolution	evolution	O	O	O	O
.	.	O	O	O	O

Administration	administration	O	O	O	O
of	of	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
resulted	resulted	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
neutralization	neutralization	O	O	O	O
of	of	O	O	O	O
viremia	viremia	O	O	OTHERS	I
and	and	O	O	O	O
a	a	O	O	O	O
drop	drop	O	O	O	O
of	of	O	O	O	O
endogenous	endogenous	O	O	O	O
interferon	interferon	O	O	OTHERS	I
titers	titers	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
average	average	O	O	O	O
time	time	O	O	O	O
of	of	O	O	O	O
death	death	O	DISEASE	OTHERS	I
was	was	O	O	O	O
delayed	delayed	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
reversible	reversible	O	O	O	O
anemia	anemia	O	DISEASE	OTHERS	I
was	was	O	O	O	O
the	the	O	O	O	O
only	only	O	O	O	O
adverse	adverse	O	O	O	O
effect	effect	O	O	O	O
observed	observed	O	O	O	O
.	.	O	O	O	O

From	from	O	O	O	O
these	these	O	O	O	O
results	results	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
an	an	O	O	O	O
antiviral	antiviral	O	O	O	O
effect	effect	O	O	O	O
in	in	O	O	O	O
advanced	advanced	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
AHF	ahf	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
that	that	O	O	O	O
anemia	anemia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
only	only	O	O	O	O
secondary	secondary	O	O	O	O
reaction	reaction	O	O	O	O
observed	observed	O	O	O	O
,	,	O	O	O	O
can	can	O	O	O	O
be	be	O	O	O	O
easily	easily	O	O	O	O
managed	managed	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
possible	possible	O	O	O	O
beneficial	beneficial	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
ribavirin	ribavirin	CHEMICALS	O	OTHERS	I
during	during	O	O	O	O
the	the	O	O	O	O
initial	initial	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
AHF	ahf	O	O	OTHERS	I
is	is	O	O	O	O
discussed	discussed	O	O	O	O
.	.	O	O	O	O

